Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-029163

Cytosorbents Corp · CTSO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
May 14, 2018
Accepted (ET)
May 16, 2018 · 2:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 14, 2018M10,000$2.90A263,304D
Common StockF2May 14, 2018S10,000$8.50D253,304D
Common StockF3holding———9,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$2.90May 14, 2018M10,000DMay 29, 2015May 29, 2023Common Stock10,0000D

Explanation of responses